L Nicklasson

750 total citations
25 papers, 583 citations indexed

About

L Nicklasson is a scholar working on Endocrinology, Diabetes and Metabolism, Economics and Econometrics and Infectious Diseases. According to data from OpenAlex, L Nicklasson has authored 25 papers receiving a total of 583 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Endocrinology, Diabetes and Metabolism, 5 papers in Economics and Econometrics and 4 papers in Infectious Diseases. Recurrent topics in L Nicklasson's work include Diabetes Management and Research (8 papers), Diabetes Treatment and Management (7 papers) and Infection Control in Healthcare (4 papers). L Nicklasson is often cited by papers focused on Diabetes Management and Research (8 papers), Diabetes Treatment and Management (7 papers) and Infection Control in Healthcare (4 papers). L Nicklasson collaborates with scholars based in United States, Switzerland and Denmark. L Nicklasson's co-authors include Marc Botteman, D Cobden, Jennifer M Lee, Andrew Palmer, William J. Valentine, William H. Lyness, Stéphane Roze, Chris L. Pashos, S Roze and Jennifer M. Lee and has published in prestigious journals such as Blood, Acta Paediatrica and Diabetes Obesity and Metabolism.

In The Last Decade

L Nicklasson

23 papers receiving 526 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
L Nicklasson United States 13 252 165 102 68 60 25 583
Xinyang Hua Australia 13 93 0.4× 27 0.2× 60 0.6× 6 0.1× 25 0.4× 25 452
Muluken Gizaw Ethiopia 18 34 0.1× 90 0.5× 406 4.0× 10 0.1× 28 0.5× 40 826
Robin D. Gorsky United States 12 39 0.2× 194 1.2× 208 2.0× 5 0.1× 32 0.5× 16 505
Ganesh Dangal Nepal 14 28 0.1× 38 0.2× 78 0.8× 23 0.3× 59 1.0× 137 657
Micki Roark United States 12 196 0.8× 23 0.1× 189 1.9× 6 0.1× 13 0.2× 20 844
Nêmora Tregnago Barcellos Brazil 15 63 0.3× 303 1.8× 141 1.4× 3 0.0× 22 0.4× 32 524
Dorothy F. Parker United States 10 43 0.2× 32 0.2× 167 1.6× 4 0.1× 16 0.3× 17 635
Hong-Jen Chang Taiwan 8 19 0.1× 184 1.1× 67 0.7× 6 0.1× 14 0.2× 8 570
Beatriz Helena Tess Brazil 12 87 0.3× 216 1.3× 304 3.0× 2 0.0× 19 0.3× 25 813
Mergan Naidoo South Africa 13 93 0.4× 33 0.2× 82 0.8× 3 0.0× 7 0.1× 64 518

Countries citing papers authored by L Nicklasson

Since Specialization
Citations

This map shows the geographic impact of L Nicklasson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L Nicklasson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L Nicklasson more than expected).

Fields of papers citing papers by L Nicklasson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L Nicklasson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L Nicklasson. The network helps show where L Nicklasson may publish in the future.

Co-authorship network of co-authors of L Nicklasson

This figure shows the co-authorship network connecting the top 25 collaborators of L Nicklasson. A scholar is included among the top collaborators of L Nicklasson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L Nicklasson. L Nicklasson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Möller, Jörgen, et al.. (2011). Cost-effectiveness of novel relapsed-refractory multiple myeloma therapies in Norway: lenalidomide plus dexamethasone vs bortezomib. Journal of Medical Economics. 14(6). 690–697. 29 indexed citations
2.
Nicklasson, L, et al.. (2011). UK Estimates of Burden of Disease Associated with Management of Intermediate-2 or High-Risk Myelodysplastic Syndromes. Blood. 118(21). 4749–4749. 3 indexed citations
3.
Chhabra, A. Bobby, L Nicklasson, Dan Greenberg, & Volker Alt. (2007). POI3 A COST-EFFECTIVENESS ANALYSIS OF RHBMP-2 IN SPINE FUSION SURGERY IN SWEDEN AND DENMARK. Value in Health. 10(3). A97–A97. 1 indexed citations
4.
Gilmer, Todd, Stéphane Roze, William J. Valentine, et al.. (2007). Cost‐Effectiveness of Diabetes Case Management for Low‐Income Populations. Health Services Research. 42(5). 1943–1959. 63 indexed citations
5.
Valentine, William J., Andrew Palmer, L Nicklasson, D Cobden, & S Roze. (2006). Improving life expectancy and decreasing the incidence of complications associated with type 2 diabetes: a modelling study of HbA1c targets. International Journal of Clinical Practice. 60(9). 1138–1145. 40 indexed citations
6.
Ray, Joshua, William J. Valentine, S Roze, et al.. (2006). Insulin therapy in type 2 diabetes patients failing oral agents: cost‐effectiveness of biphasic insulin aspart 70/30 vs. insulin glargine in the US*. Diabetes Obesity and Metabolism. 9(1). 103–113. 23 indexed citations
7.
Stockl, Karen M., Ann Vanderplas, L Nicklasson, et al.. (2006). An evaluation of patient preference for an alternative insulin delivery system compared to standard vial and syringe. Current Medical Research and Opinion. 23(1). 133–146. 59 indexed citations
8.
Lee, Won Chan, L Nicklasson, D Cobden, et al.. (2005). Short-term economic impact associated with occupational needlestick injuries among acute care nurses. Current Medical Research and Opinion. 21(12). 1915–1922. 17 indexed citations
9.
Lee, Jennifer M., Marc Botteman, L Nicklasson, D Cobden, & Chris L. Pashos. (2005). Needlestick injury in acute care nurses caring for patients with diabetes mellitus: a retrospective study. Current Medical Research and Opinion. 21(5). 741–747. 51 indexed citations
10.
Valentine, William J., Andrew Palmer, Morten Lammert, et al.. (2005). Long-term clinical and cost outcomes of treatment with biphasic insulin aspart 30/70 versus insulin glargine in insulin naïve type 2 diabetes patients: cost-effectiveness analysis in the UK setting. Current Medical Research and Opinion. 21(12). 2063–2071. 21 indexed citations
11.
Lee, Jennifer M, et al.. (2005). Needlestick Injuries in the United States: Epidemiologic, Economic, and Quality of Life Issues. AAOHN Journal. 53(3). 117–133. 148 indexed citations
12.
Palmer, Andrew, Stéphane Roze, William J. Valentine, et al.. (2004). Deleterious Effects of Increased Body Weight Associated with Intensive Insulin Therapy for Type 1 Diabetes: Increased Blood Pressure and Worsened Lipid Profile Partially Negate Improvements in Life Expectancy. Current Medical Research and Opinion. 20(sup1). S67–S73. 13 indexed citations
13.
14.
Jee, Yong‐Seok, Marc Botteman, & L Nicklasson. (2004). A Systematic Review of the Economic and Humanistic Burden of Needlestick Injury in the United States. American Journal of Infection Control. 32(3). E43–E43. 3 indexed citations
15.
16.
Shelmet, J J, Sherwyn Schwartz, Gregory M. Peterson, et al.. (2003). Preference and resource utilization in elderly patients: InnoLet® versus vial/syringe. Diabetes Research and Clinical Practice. 63(1). 27–35. 58 indexed citations
17.
18.
Nicklasson, L, et al.. (2003). PDB18: ESTIMATING THE COST-EFFECTIVENESS OF REPAGLINIDE PLUS METFORMIN VS. NATEGLINIDE PLUS METFORMIN OVER A 30-YEAR PERIOD. Value in Health. 6(3). 333–334. 2 indexed citations
19.
Andréasson, Sven, Mats Berglund, Johan Franck, et al.. (2001). Behandling av alkohol- och narkotikaproblem: En evidensbaserad kunskapssammanställning. Lund University Publications (Lund University). 2 indexed citations
20.
Nicklasson, L & Sören Höjgård. (1999). Cost‐analysis of management strategies for children with vesico‐ureteric reflux. Acta Paediatrica. 88(s431). 79–86. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xinyang Hua Breakdown of academic impact, for papers by Muluken Gizaw Breakdown of academic impact, for papers by Robin D. Gorsky Breakdown of academic impact, for papers by Ganesh Dangal Breakdown of academic impact, for papers by Micki Roark Breakdown of academic impact, for papers by Nêmora Tregnago Barcellos Breakdown of academic impact, for papers by Dorothy F. Parker Breakdown of academic impact, for papers by Hong-Jen Chang Breakdown of academic impact, for papers by Beatriz Helena Tess Breakdown of academic impact, for papers by Mergan Naidoo
Rankless by CCL
2026